SCHEMBL26198577

SCHEMBL26198577

O=C(CNC(=O)c1ccccc1)NCCO

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.58
KMT2A Q03164 2/20 0.58
MEN1 O00255 1/20 0.58
GPR139 Q6DWJ6 1/20 0.54
TSHR P16473 1/20 0.53
RECQL P46063 1/20 0.53
POLB P06746 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
LMNA P02545 1/20 0.50
MMP1 P03956 1/20 0.50
SLC6A9 P48067 1/20 0.49
SLC6A5 Q9Y345 1/20 0.49
EPHX2 P34913 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
PRSS1 P07477 1/20 0.49
CTSG P08311 1/20 0.49
CTRB1 P17538 1/20 0.49
CMA1 P23946 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL305562 0.87 GAA (0.65) GAAKMT2ARECQLPOLBSMN1; SMN2
Hydrochloric Acid SCHEMBL6421806 0.85 GAA (0.63) GAAKMT2ARECQLPOLBSMN1; SMN2
SCHEMBL9829615 0.84 GAA (0.57) GAAKMT2AMEN1GPR139TSHR
SCHEMBL9545406 0.84 NAAA (0.58) GAAKMT2AMEN1GPR139TSHR
Benzoic Acid SCHEMBL3096844 0.81 GAA (0.59) GAAKMT2ATSHRRECQLPOLB
SCHEMBL7293621 0.81 KDM4E (0.59) GAAKMT2AMEN1GPR139TSHR
SCHEMBL7515133 0.81 KDM4E (0.59) GAAKMT2AMEN1GPR139TSHR
SCHEMBL14219224 0.81 NAAA (0.69) GAAKMT2AMEN1GPR139TSHR
SCHEMBL1246967 0.80 LMNA (0.61) GAAKMT2AMEN1RECQLPOLB
SCHEMBL7412271 0.79 MMP1 (0.73) GAAGPR139MMP1SLC6A9SLC6A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250074887-A1 PHARMACEUTICAL COMPOSITIONS OF 6-(2-(2H-TETRAZOL-5-YL)ETHYL)DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AND DERIVATIVES THEREOF Sea Pharmaceuticals LLC. (US) 2025-03-06 US disclosed
WO-2023130008-A2 PHARMACEUTICAL COMPOSITIONS OF 6-(2-(2H-TETRAZOL-5-YL)ETHYL)DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AND DERIVATIVES THEREOF SEA PHARMACEUTICALS LLC (US) 2023-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250074887-A1 PHARMACEUTICAL COMPOSITIONS OF 6-(2-(2H-TETRAZOL-5-YL)ETHYL)DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AND DERIVATIVES THEREOF GABRQ, GRIK5, CYP3A7 GAA 361/4885KMT2A 1192/4885MEN1 1622/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.